Market cap of Akanda Corp. [AKAN] reaches 27.30M – now what?


Akanda Corp. [NASDAQ: AKAN] closed the trading session at $0.90 on 07/12/22. The day’s price range saw the stock hit a low of $0.835, while the highest price level was $1.17. The company report on July 12, 2022 that Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Provides Tetra with stable supply of high-quality ingredients and regulatory-approved services to satisfy clinical trials and prescription products.

Diversifies Akanda into cancer pain medical market as a specialized manufacturer of cannabis-based drugs for use in FDA clinical trials and pharmaceutical markets.

The stocks have a year to date performance of -91.43 percent and weekly performance of 15.06 percent. The stock has performed 8.06 percent around the most recent 30 days and changed -89.73 percent over the most recent 3-months.

If compared to the average trading volume of 730.31K shares, AKAN reached to a volume of 37827320 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here’s what leading stock market gurus have to say about Akanda Corp. [AKAN]:

The Average True Range (ATR) for Akanda Corp. is set at 0.13, with the Price to Sales ratio for AKAN stock in the period of the last 12 months amounting to 658.85.

AKAN stock trade performance evaluation

Akanda Corp. [AKAN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 15.06.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AKAN stock in for the last two-week period is set at 36.53, with the RSI for the last a single of trading hit 51.16, and the three-weeks RSI is set at 32.57 for Akanda Corp. [AKAN]. The present Moving Average for the last 50 days of trading for this stock 1.9037, while it was recorded at 0.7918 for the last single week of trading.

Akanda Corp. [AKAN]: An insightful look at the core fundamentals

Akanda Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.50 and a Current Ratio set at 0.50.

Akanda Corp. [AKAN]: Insider Ownership positions

There are presently around $0 million, or 1.00% of AKAN stock, in the hands of institutional investors. The top three institutional holders of AKAN stocks are: MILLENNIUM MANAGEMENT LLC with ownership of 23,795, which is approximately New of the company’s market cap and around 72.86% of the total institutional ownership; JANE STREET GROUP, LLC, holding 11,129 shares of the stock with an approximate value of $9000.0 in AKAN stocks shares; and SUSQUEHANNA INTERNATIONAL GROUP, LLP, currently with $8000.0 in AKAN stock with ownership of nearly New of the company’s market capitalization.

6 institutional holders increased their position in Akanda Corp. [NASDAQ:AKAN] by around 52,487 shares. Additionally, 0 investors decreased positions by around 0 shares, while 0 investors held positions by with 0 shares. The mentioned changes placed institutional holdings at 52,487 shares, according to the latest SEC report filing. AKAN stock had 6 new institutional investments in for a total of 52,487 shares, while 0 institutional investors sold positions of 0 shares during the same period.